Skip to main content

This is Moderna's Canada website

It may contain content that is not applicable to your location

Welcome to the mRNA Suite

    Due to the flexibility of our platform, mRNA technology enables the efficient production of new products in a continuously evolving global healthcare system. We believe that if mRNA can be used to treat one disease, it can treat many diseases.

    • mRNA acts as the body’s instructions for producing a specific protein—enabling the body to make its own medicine.

    • mRNA vaccines enhance the body’s immune response. mRNA is also being studied as potential therapeutic for diseases like cancer.

    • In Vitro (no cells needed) production eliminates biological safety concerns.

    • Single-use technology enables fast turnaround time between batches.

    🇨🇦Canada > Welcome to the mRNA Suite > Hero

    Process for Manufacturing Our GMP Commercial mRNA Drug Substance

    1. Supply Chain & Material Technicians – Receive and deliver raw materials 

    2. Drug Substance – Generate and formulate the mRNA from a DNA sequence 

    3. Quality Control (QC) – Conducts release testing 

    4. Shipping – Ships products to final fill 

    🇨🇦Canada > Process for Manufacturing Our GMP Commercial mRNA Drug Substance > Image